These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8480847)

  • 1. Serotonin and Parkinson's disease.
    Hesselink JM
    Am J Psychiatry; 1993 May; 150(5):843-4. PubMed ID: 8480847
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin syndrome produced by a combination of fluoxetine and lithium.
    Muly EC; McDonald W; Steffens D; Book S
    Am J Psychiatry; 1993 Oct; 150(10):1565. PubMed ID: 8379573
    [No Abstract]   [Full Text] [Related]  

  • 3. The serotonin syndrome.
    Sternbach H
    Am J Psychiatry; 1991 Jun; 148(6):705-13. PubMed ID: 2035713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Depression and Parkinson syndrome].
    Schnaberth G
    Wien Med Wochenschr; 1986 Aug; 136(15-16):391-3. PubMed ID: 2878539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selegiline, fluoxetine, and depression in Parkinson's disease.
    Garcia-Monco JC; Padierna A; Gomez Beldarrain M
    Mov Disord; 1995 May; 10(3):352. PubMed ID: 7651457
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacotherapy of Parkinson's disease.
    Cohen MM; Scheife RT
    Am J Hosp Pharm; 1977 May; 34(5):531-8. PubMed ID: 326045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression in Parkinson's disease: a biochemical model.
    Sano M; Stern Y; Cote L; Williams JB; Mayeux R
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):88-92. PubMed ID: 2136066
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine receptors in the basal ganglia: relevance to Parkinson's disease.
    Strange PG
    Mov Disord; 1993 Jul; 8(3):263-70. PubMed ID: 8101967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinergic effects in a depressed parkinsonian patient.
    Huszonek JJ
    J Geriatr Psychiatry Neurol; 1995 Apr; 8(2):100-2. PubMed ID: 7794471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression in Parkinson's disease: reconciling physiological and psychological perspectives.
    Taylor AE; Saint-Cyr JA
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):92-8. PubMed ID: 2136067
    [No Abstract]   [Full Text] [Related]  

  • 11. L-tryptophan supplementation in Parkinson's disease.
    Sandyk R; Fisher H
    Int J Neurosci; 1989 Apr; 45(3-4):215-9. PubMed ID: 2744962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Montastruc JL; Schmitt L; Bagheri H
    Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal ganglia disease.
    Marsden CD
    Lancet; 1982 Nov; 2(8308):1141-7. PubMed ID: 6128460
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluoxetine and selegiline--lack of significant interaction.
    Waters CH
    Can J Neurol Sci; 1994 Aug; 21(3):259-61. PubMed ID: 8000982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenelzine treatment of depression in Parkinson's disease.
    Hargrave R; Ashford JW
    Am J Psychiatry; 1992 Dec; 149(12):1751-2. PubMed ID: 1443257
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome without neuroleptics.
    Parsa MA; Rohr T; Ramirez LF; Meltzer HY
    J Clin Psychopharmacol; 1990 Dec; 10(6):437-8. PubMed ID: 2286714
    [No Abstract]   [Full Text] [Related]  

  • 17. The "serotonin hypothesis" for depression in Parkinson's disease.
    Mayeux R
    Adv Neurol; 1990; 53():163-6. PubMed ID: 2239456
    [No Abstract]   [Full Text] [Related]  

  • 18. Depression in Parkinson's disease.
    Murray JB
    J Psychol; 1996 Nov; 130(6):659-67. PubMed ID: 8914304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease and pain--nondopaminergic mechanisms are likely to be important too.
    Lim SY; Farrell MJ; Evans AH
    Mov Disord; 2011 Jun; 26(7):1353-4. PubMed ID: 21449013
    [No Abstract]   [Full Text] [Related]  

  • 20. Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy.
    Melamed E; Zoldan J; Friedberg G; Ziv I; Weizmann A
    Adv Neurol; 1996; 69():545-50. PubMed ID: 8615179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.